Zobrazeno 1 - 10
of 305
pro vyhledávání: '"Linnert, M."'
HQM is an optical broad-band photometric monitoring program carried out since September 1988. We use a CCD camera at the MPIA 1.2$\,$m telescope. Fully automatic photometric reduction relative to stars in the frames is done within a few minutes after
Externí odkaz:
http://arxiv.org/abs/astro-ph/9403050
HQM is an optical broad-band photometric monitoring program carried out since Sept.~1988. We use a CCD camera equipped to the MPIA 1.2$\,$m telescope. Fully automatic photometric reduction relative to stars in the frames is done within a few minutes
Externí odkaz:
http://arxiv.org/abs/astro-ph/9403049
Autor:
Linnert, M., Fritz, C., Jäger, C., Schlenzig, D., Ramsbeck, D., Kleinschmidt, M., Wermann, M., Demuth, H.-U., Parthier, C., Schilling, S.
The astacin protease Meprin v represents an emerging target for drug development due to its potential involvement in disorders such as acute and chronic kidney injury and fibrosis. Here, we elaborate on the structural basis of inhibition by a specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::198e6ec3a8f116da17d8efa81a3e82ae
https://publica.fraunhofer.de/handle/publica/268639
https://publica.fraunhofer.de/handle/publica/268639
Autor:
Linnert M; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Fritz C; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Jäger C; Vivoryon Therapeutics N. V., Weinbergweg 22, 06120 Halle (Saale), Germany., Schlenzig D; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Ramsbeck D; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Kleinschmidt M; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Wermann M; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany., Demuth HU; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany.; Faculty of Applied Biosciences and Process Engineering, Anhalt University of Applied Sciences, Bernburger Street 55, 06366 Köthen, Germany., Parthier C; Institute of Biochemistry and Biotechnology, Charles-Tanford-Proteinzentrum, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Street 3a, 06120 Halle (Saale), Germany., Schilling S; Fraunhofer Institute for Cell Therapy and Immunology, Department of Drug Design and Target Validation, Weinbergweg 22, 06120 Halle (Saale), Germany.; Faculty of Applied Biosciences and Process Engineering, Anhalt University of Applied Sciences, Bernburger Street 55, 06366 Köthen, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 May 26; Vol. 22 (11). Date of Electronic Publication: 2021 May 26.
Autor:
Taudte N; Fraunhofer Institute for Cell Therapy and Immunology, Germany., Linnert M; Fraunhofer Institute for Cell Therapy and ImmunologyMax Planck Research Unit for Enzymology of Protein Folding, Germany., Rahfeld JU; Fraunhofer Institute for Cell Therapy and ImmunologyMax Planck Research Unit for Enzymology of Protein Folding, Germany., Piechotta A; Fraunhofer Institute for Cell Therapy and Immunology., Ramsbeck D; Fraunhofer IZI-MWT., Buchholz M; Fraunhofer IZI-MWT, Germany., Kolenko P; Martin-Luther-University Halle-Wittenberg, Germany., Parthier C; Institute of Biotechnology, Martin Luther University Halle-Wittenberg., Houston JA; University of Louisville, School of Dentistry, United States., Veillard F; Jagiellonian University, Faculty of Biochemistry, Poland., Eick S; University of Bern, Department of Periodontology, Switzerland., Potempa J; Jagiellonian University, Poland., Schilling S; Fraunhofer Institute for Cell Therapy and Immunology., Demuth HU; Fraunhofer Institute for Cell Therapy and Immunology, Germany., Stubbs MT 2nd; Institut für Biochemie und Biotechnologie, Martin Luther University Halle-Wittenberg, Germany.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2021 Jan 05. Date of Electronic Publication: 2021 Jan 05.
Autor:
Fang, Chaowei1 (AUTHOR) fangchaowei@htu.edu.cn, Wu, Jiajing2 (AUTHOR) wujj109@163.com, Liang, Weihong1 (AUTHOR) liangwh@htu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p9045. 21p.
Autor:
Tassone, Giusy1 (AUTHOR) giusy.tassone@unisi.it, Pozzi, Cecilia1,2 (AUTHOR) cecilia.pozzi@unisi.it, Mangani, Stefano1 (AUTHOR) cecilia.pozzi@unisi.it
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8279. 14p.
Autor:
Hartlage-Rübsamen M; Paul Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany. maikerbs@rz.uni-leipzig.de., Bluhm A; Paul Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany. alexandra.bluhm@medizin.uni-leipzig.de., Piechotta A; Department of Molecular Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology, 06120 Halle (Saale), Germany. anke.piechotta@izi.fraunhofer.de., Linnert M; Department of Molecular Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology, 06120 Halle (Saale), Germany. miriam.linnert@izi.fraunhofer.de., Rahfeld JU; Department of Molecular Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology, 06120 Halle (Saale), Germany. jens-ulrich.rahfeld@izi.fraunhofer.de., Demuth HU; Department of Molecular Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology, 06120 Halle (Saale), Germany. Hans-Ulrich.Demuth@izi.fraunhofer.de., Lues I; Probiodrug AG, 06120 Halle (Saale), Germany. Inge.lues@probiodrug.de., Kuhn PH; Institute of Pathology, Technical University of Munich, 81675 Munich, Germany. Peer.Kuhn@tum.de., Lichtenthaler SF; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), 81377 Munich, Germany. stefan.lichtenthaler@dzne.de.; Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany. stefan.lichtenthaler@dzne.de.; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany. stefan.lichtenthaler@dzne.de.; Institute for Advanced Study, Technical University of Munich, 85748 Garching, Germany. stefan.lichtenthaler@dzne.de., Roßner S; Paul Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany. steffen.rossner@medizin.uni-leipzig.de., Höfling C; Paul Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany. corinna.hoefling@medizin.uni-leipzig.de.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2018 Apr 17; Vol. 23 (4). Date of Electronic Publication: 2018 Apr 17.
Autor:
Han, Yuetao1 (AUTHOR) hytp0402@163.com, Zhao, Peiyue1,2 (AUTHOR) zpy837643595@163.com, Zhao, Yuan1,3 (AUTHOR) zy991108@126.com, Liu, Min1,3 (AUTHOR) lm7005210225@163.com, Guo, Erhu1,2 (AUTHOR) guoerhu2003@163.com, Wang, Guoliang1,2 (AUTHOR) wangguoliangwz@126.com, Zhang, Aiying1,2,3 (AUTHOR) zay1012@126.com
Publikováno v:
Agronomy. Jun2024, Vol. 14 Issue 6, p1114. 20p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.